News

Armed with a poisonous scorpion and glowing Tumor Paint, Blaze Bioscience takes on cancer
July 9, 2014
Puget Sound Business Journal

One Doctor's Quest to Save People by Injecting Them With Scorpion Venom
June 24, 2014
WIRED Magazine

Blaze Made Venture Beat Top Startup List
26 Amazing Startups You Need to Watch in 2014
December 31, 2013

Blaze Bioscience Announces Initiation of First-in-Human Phase 1 Clinical Study of BLZ-100
December 19, 2013

Blaze Bioscience Raises $9 million in Series B Financing
December 3, 2013

Blaze Co-Founder Dr. Jim Olson Featured on NPR Morning Edition
Treating Kids' Cancer With Science and A Pocket Full of Hope
September 13, 2013

Why Painting Tumors Could Make Brain Surgeons Better
September 12, 2013

Blaze Bioscience and Fred Hutchinson Cancer Research Center Enter into Collaboration and Option Agreement in Support of Optides Discovery Program
July 3, 2013

Blaze Bioscience Announces Two Poster Presentations at AACR-SNMMI Conference and Award of NCI SBIR Contract Advancing Tumor Paint™ Technology
February 27, 2013

Blaze Bioscience Announces Completion of Series A Financing - Brings Total Investment to $9.8 Million
February 22, 2013

Blaze Bioscience's brilliant concept in the fight against cancer 
September 2012
Seattle Business Magazine

Blaze Bioscience Raises $5.0 Million in Series A Financing
June 8, 2012 

Blaze Co-Founder Dr. Jim Olson Featured in Promotional Video
May 14, 2012 

Blaze Bioscience President and CEO Heather Franklin will speak at Xconomy Forum: Reinventing Biotech’s Business Model
April 3, 2012
Xconomy

Blaze Bioscience, Fred Hutch Spinoff with Zymo Vet at the Helm, Seeks to “Paint” Tumors
October 18, 2011
Xconomy 

Blaze Bioscience licenses Tumor Paint Technology from Fred Hutchinson Cancer Research Center
October 18, 2011